Cannabidiol [CBD] is an inspiration for therapeutic compounds at the forefront of research being conducted at Pure Green Pharmaceuticals. Led by Steve Goldner, the clinical trials being conducted showcase the potential of reducing suffering through therapeutic CBD.
The therapeutic CBD clinical trials suggest that medical CBD can provide pain relief, reduce anxiety, and alleviate nerve pain without impacting brain function. The medical CBD experts at Pure Green Pharmaceuticals have made strides in a patient-centered approach for developing CBD therapeutics that relieve pain, aid in sleep, and reduce anxiety. The therapeutic CBD used in clinical trials by Pure Green Pharmaceuticals meets FDA validation standards. The CBD therapeutic clinical trials will help medical CBD experts understand not only the effectiveness, but also the compounds driving the effects.
The water soluble tablet developed by Pure Green Pharmaceuticals dissolves in 60 seconds under the tongue and is absorbed efficiently into the bloodstream to begin the therapeutic CBD effects. The company has four CBD-based therapeutic pharmaceutical clinical trials listed on the NIH website, www.cliicaltrials.gov.
Pure Green Pharmaceuticals is actively running clinical trials for the therapeutic effects of CBD for men and women with musculoskeletal pain, women with menstrual pain, and those dealing with diabetic neuropathy as a result of diabetic complications.
The medical CBD experts at Pure Green Pharmaceuticals are committed to obtaining the FDA’s approval to market prescription for therapeutic CBD pharmaceutical products and will continue to advance the industry to improve the safe and effective use of CBD.